Meeting
2016 ASCO Annual Meeting
Determination of the effect of target site density on the efficacy of CD22 chimeric antigen receptor t-cell therapy to treat acute lymphoblastic leukemia.
Authors
Sang Nguyen
Biotechnology Department, Johns Hopkins University, Baltimore, MD
Sang Nguyen , Robbie G. Majzner , Christopher Chien , Haiying Qin , Terry Fry
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Leukemia/Lymphoma
Citation
J Clin Oncol 34, 2016 (suppl; abstr 10536)
DOI
10.1200/JCO.2016.34.15_suppl.10536
Abstract #
10536
Poster Bd #
227
Abstract Disclosures
Similar Posters
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Targeting CD19-negative relapsed B-acute lymphoblastic leukemia using trivalent CAR T cells.
First Author: Kristen Fousek
First Author: Marco L. Davila
Poster
2023 ASCO Annual Meeting
Examining safety and durable disease remission in R/R B-ALL after autologous CD19-directed CAR T cells produced by novel PRIMCAR manufacture platform.
First Author: Zhi Yang
Poster
2023 ASCO Annual Meeting
Safety and efficacy profile of a very low dose of MC-1-50 for treatment of r/r NHL.
First Author: Shiqi Li